Metagenomi Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2023 | — | -175.4% | -152.5% |
| FY2024 | — | -170.0% | -149.3% |
| FY2025 | — | -380.9% | -348.5% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2023 | — | -175.4% | -152.5% |
| FY2024 | — | -170.0% | -149.3% |
| FY2025 | — | -380.9% | -348.5% |